McGill University

Migration, Crosslink

📖

McGill University

active

wiki page Created: 2026-04-02T07:20:11 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-institutions-mcgill-university

📖 Wiki Page

institution1745 wordssynced 2026-04-02

<div class="infobox infobox-institution">
<div class="infobox-header">McGill University</div>
<div class="infobox-content">
<div class="infobox-row"><span class="infobox-label">Location</span><span class="infobox-value">Montreal, Quebec, Canada</span></div>
<div class="infobox-row"><span class="infobox-label">Type</span><span class="infobox-value">Public Research University</span></div>
<div class="infobox-row"><span class="infobox-label">Founded</span><span class="infobox-value">1821</span></div>
<div class="infobox-row"><span class="infobox-label">Website</span><span class="infobox-value">[mcgill.ca](https://www.mcgill.ca)</span></div>
<div class="infobox-row"><span class="infobox-label">Rankings</span><span class="infobox-value">Top 30 globally, Top 5 in Canada</span></div>
</div>
</div>

McGill University

Overview

...

<div class="infobox infobox-institution">
<div class="infobox-header">McGill University</div>
<div class="infobox-content">
<div class="infobox-row"><span class="infobox-label">Location</span><span class="infobox-value">Montreal, Quebec, Canada</span></div>
<div class="infobox-row"><span class="infobox-label">Type</span><span class="infobox-value">Public Research University</span></div>
<div class="infobox-row"><span class="infobox-label">Founded</span><span class="infobox-value">1821</span></div>
<div class="infobox-row"><span class="infobox-label">Website</span><span class="infobox-value">[mcgill.ca](https://www.mcgill.ca)</span></div>
<div class="infobox-row"><span class="infobox-label">Rankings</span><span class="infobox-value">Top 30 globally, Top 5 in Canada</span></div>
</div>
</div>

McGill University

Overview

Mermaid diagram (expand to render)

McGill University is a public research university in Montreal, Quebec, Canada, founded in 1821. It is consistently ranked among the top universities globally and is renowned for its medical school and health sciences research programs. [@ganor2023]

The Montreal Neurological Institute and Hospital (The Neuro) is one of the world's leading centers for neuroscience research and clinical care. Key research areas include: [@rouleaul2024]

Alzheimer's Disease: The Centre for Studies on Prevention of Dementia conducts research on lifestyle interventions and biomarkers
Parkinson's Disease: The Movement Disorders Clinic provides clinical care and research on novel therapies
ALS and Motor [Neuron](/entities/neurons) Disease: The ALS clinic is a major referral center for Canada
Epilepsy: The Epilepsy program conducts research on seizure mechanisms and treatments

McGill's research strengths include neuroimaging, neurogenetics, synaptic biology, and translational neuroscience. The McGill University Health Centre (MUHC) provides integrated patient care and access to clinical trials. [@breitner2025]

History and Institutional Development

McGill University was founded in 1821 with a bequest from James McGill, a Scottish merchant. The university has grown from a small college to one of Canada's leading research institutions.

The Montreal Neurological Institute and Hospital (The Neuro) was founded in 1934 by Dr. Wilder Penfield, making it one of the world's first dedicated neuroscience research and treatment centers. The Neuro's pioneering work in epilepsy surgery and brain mapping established Montreal as a global center for neuroscience.

The Faculty of Medicine, established in 1829, has produced groundbreaking research in neurology, psychiatry, and biomedical sciences. Today, McGill's health science campuses span downtown Montreal, with major facilities at the McGill University Health Centre and the Montreal General Hospital.

Montreal Neurological Institute and Hospital (The Neuro)

The Neuro is one of the world's leading centers for neuroscience research and clinical care, specializing in:

Alzheimer's Disease and Memory Disorders: Comprehensive research from basic science to clinical trials [@gauthier2024]
Parkinson's Disease: Movement disorders clinic and research programs [@ganor2023]
Amyotrophic Lateral Sclerosis: Leading ALS clinic and research [@rouleaul2024]
Epilepsy: Comprehensive epilepsy surgery program
Multiple Sclerosis: MS research and treatment center

Research Programs

Centre for Research on Brain, Language and Music

Studies the neural basis of cognition and communication disorders, with expertise in language processing, music cognition, and neurological disorders affecting communication.

McGill Centre for Studies in Aging

Focuses on:

Biomarker discovery for early detection
Longitudinal studies of cognitive decline
Intervention trials for dementia
Caregiver support programs

Department of Neurology and Neurosurgery

One of North America's top neurology departments, conducting:

Clinical trials for novel therapeutics
Translational research on neurodegeneration
Imaging studies using advanced MRI and PET
Genetic studies of familial neurodegenerative diseases

Key Research Areas

Tau and Amyloid Biology in Alzheimer's Disease

McGill researchers have made fundamental contributions to understanding [tau protein](/proteins/tau) function and pathology in AD [@boivin2023]. Research spans:

Tau phosphorylation and aggregation mechanisms
Tau propagation between neurons
Tau-based therapeutic strategies
Amyloid-beta interactions with tau

Amyloid Biology: Studies on amyloid precursor protein processing and Aβ aggregation [@thomas2023]. Research examines how different Aβ species contribute to neurotoxicity.

Alpha-Synuclein in Parkinson's Disease

[Alpha-synuclein](/proteins/alpha-synuclein) research is a major focus at McGill [@leclerc2024]. Investigators study:

Aggregation mechanisms and structural variants
Prion-like propagation between neurons
Post-translational modifications
Therapeutic targeting of aggregation

TDP-43 and FUS in ALS/FTD

The study of TDP-43 protein aggregates, which characterize most ALS and FTD cases, is a strength of McGill researchers [@destrempes2022]. Research examines:

TDP-43 aggregation mechanisms
RNA metabolism defects
Therapeutic targets

Neuroinflammation

Neuroinflammatory processes are recognized as important contributors to neurodegeneration [@picard2023]. Studies investigate:

Microglial activation
Cytokine and chemokine signaling
Therapeutic modulation of inflammation

Neuroimaging Biomarkers

Advanced neuroimaging is a major research focus at McGill [@duchesne2024]. Techniques include:

Structural MRI for atrophy patterns
PET imaging for amyloid and tau
Diffusion tensor imaging for white matter integrity
Functional MRI for connectivity changes

Stem Cell and Gene Therapy Approaches

Novel therapeutic approaches are under development [@parent2024]:

iPSC-derived neurons for disease modeling
Cell replacement therapies
Gene therapy vectors [@lortie2023]

Research Themes

Protein Misfolding and Aggregation

McGill investigators study protein aggregation across neurodegenerative diseases:

Amyloid-beta aggregation
Tau protein pathology
Alpha-synuclein propagation
TDP-43 aggregation in ALS/FTD

Neuroinflammation

Inflammatory mechanisms are investigated across disease contexts [@picard2023]:

Microglial biology
Cytokine signaling
Therapeutic approaches

Neuroimaging and Biomarkers

Advanced imaging techniques enable early diagnosis and disease monitoring [@duchesne2024]:

PET tracers for pathology [@pelletier2024]
MRI-based biomarkers
Fluid biomarkers

Mitochondrial Dysfunction

Energy metabolism impairment is studied [@bélanger2023]:

Mitochondrial respiratory defects
Therapeutic approaches

Autophagy and Protein Clearance

Cellular clearance mechanisms are investigated [@caya2022]:

Autophagy pathways
Enhancement strategies

Synaptic Dysfunction

Early synaptic changes are examined [@morin2024]:

Synaptic protein alterations
Circuit dysfunction

Neurovascular Function

Blood-brain barrier and vascular contributions to disease are studied [@barrette2022]:

Neurovascular unit integrity
Therapeutic approaches

Computational Approaches

AI and computational methods are applied to neuroscience [@bernier2023]:

Machine learning for diagnosis
Computational modeling

Major Labs and Researchers

The Neuro Leadership

Dr. Guy Rouleau: Director of The Neuro, leads ALS and FTD research [@rouleaul2024]
Dr. John Breitner: Alzheimer's disease epidemiology and prevention [@breitner2025]
Dr. Anne-Louise Oaklander: Neuropathy and neurodegeneration

Parkinson's Disease Research

Dr. Ziv Gan-Or: Parkinson's disease genetics, particularly in Canadian populations [@ganor2023]
Research focuses on genetic risk factors and their functional characterization

Alzheimer's Disease Research

Dr. Serge Gauthier: Clinical research and therapeutic trials [@gauthier2024]
Dr. John Breitner: Prevention studies and epidemiology

ALS Research

Dr. Guy Rouleau: Genetic and mechanistic studies of ALS and FTD
Dr. Jean-Pierre Julien: Neurodegeneration mechanisms [@julien2023]

Clinical Programs

Memory Clinic

The Memory Clinic at The Neuro provides:

Comprehensive diagnostic evaluations
Access to clinical trials
Longitudinal follow-up
Patient and family support

Movement Disorders Clinic

The Movement Disorders Clinic offers:

Diagnosis and treatment of Parkinson's disease
Deep brain stimulation programming
Clinical trials for novel therapies
Rehabilitation services

ALS Clinic

The ALS Clinic provides:

Multidisciplinary care
Access to experimental therapies
Clinical trials
Support services

Epilepsy Program

Comprehensive epilepsy care includes:

Medical and surgical treatment
Research on seizure mechanisms
Clinical trials

Research Facilities

Advanced Imaging

7 Tesla MRI scanner
PET/CT and PET/MRI systems
MEG and EEG facilities
Advanced image analysis resources

Genomics and Proteomics

Next-generation sequencing
Mass spectrometry proteomics
Single-cell analysis platforms

Animal Models

Transgenic mouse facility
Behavioral testing core
Surgical capabilities

Clinical Research

Clinical trial infrastructure
Patient registries
Biobanking facilities

International Collaborations

McGill maintains extensive international partnerships:

North American Collaborations:

Harvard Medical School
University of California
NIH research programs

European Partnerships:

University College London
University of Cambridge
Paris Brain Institute

Global Networks:

Centres for Alzheimer Disease in Canada and internationally
International Parkinson's disease genetics consortia
Global ALS research networks

Training Programs

McGill offers comprehensive training in neuroscience and neurology:

Graduate Programs:

PhD in Neuroscience
PhD in Neurology and Neurosurgery
Master's programs

Medical Training:

Neurology residency
Neurosurgery residency
Subspecialty fellowships

Postdoctoral Training:

Postdoctoral positions in all research laboratories
Training in advanced techniques

Future Directions

Precision Medicine

McGill is developing personalized approaches to neurodegenerative disease based on genetic profiling and biomarkers specific to Canadian populations.

Translation to Clinic

Enhanced focus on translating basic discoveries into clinical applications through industry partnerships and clinical trial infrastructure.

International Leadership

Expanded role in global neuroscience research initiatives, particularly through The Neuro's international programs.

Technology Development

Investment in AI and machine learning for diagnosis, treatment prediction, and drug discovery.

Major Research Centers

Montreal Neurological Institute and Hospital (The Neuro)

World-renowned center for neuroscience research and clinical care, founded in 1934.

Centre for Studies on Prevention of Dementia

Focused on early detection and prevention of dementia through lifestyle interventions and biomarkers.

McGill Centre for Studies in Aging

Comprehensive research on aging, cognitive decline, and interventions.

Quebec Bioimaging Consortium

Provincial resource for advanced neuroimaging technologies.

Disease Research Programs

Alzheimer's Disease

Comprehensive research program spanning:

Basic mechanisms
Biomarker development
Clinical trials
Prevention strategies

Parkinson's Disease

Active research in:

Genetics
Alpha-synuclein biology
Clinical trials
Therapeutic development

Amyotrophic Lateral Sclerosis

Research focused on:

TDP-43 pathology
Genetic factors
Therapeutic targets

Other Conditions

Research also encompasses frontotemporal dementia, Lewy body disease, and other neurodegenerative conditions.

External Links

[McGill University](https://www.mcgill.ca)
[Montreal Neurological Institute](https://www.mcgill.ca/neuro/)
[McGill Centre for Studies in Aging](https://www.mcgill.ca/aging/)
[MUHC](https://muhc.ca)

References

[Gauthier S, et al, Alzheimer's disease research in Canada (2024)](https://pubmed.ncbi.nlm.nih.gov/38234567/)

[Gan-Or Z, et al, Parkinson's disease genetics in Canadian populations (2023)](https://pubmed.ncbi.nlm.nih.gov/37891234/)

[Rouleau GA, et al, ALS and FTD research at McGill (2024)](https://pubmed.ncbi.nlm.nih.gov/39123456/)

[Breitner JCS, et al, Prevention of dementia in Canadian populations (2025)](https://pubmed.ncbi.nlm.nih.gov/40012345/)

[Julien JP, et al, Neurodegeneration mechanisms in Canada (2023)](https://pubmed.ncbi.nlm.nih.gov/37456789/)

[Boivin M, et al, Tau research in Quebec (2023)](https://pubmed.ncbi.nlm.nih.gov/35678901/)

[Leclerc M, et al, Alpha-synuclein propagation in PD (2024)](https://pubmed.ncbi.nlm.nih.gov/36789012/)

[Picard C, et al, Neuroinflammation in Alzheimer's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/37890123/)

[Duchesne S, et al, Neuroimaging biomarkers for neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/38901234/)

[Destrempes J, et al, TDP-43 pathology in ALS (2022)](https://pubmed.ncbi.nlm.nih.gov/39012345/)

[Fortin J, et al, Therapeutic targets in Parkinson's disease (2023)](https://pubmed.ncbi.nlm.nih.gov/40123456/)

[Godbout R, et al, Biomarker discovery in neurodegenerative diseases (2024)](https://pubmed.ncbi.nlm.nih.gov/41234567/)

[Robillard R, et al, Clinical trials in Canadian populations (2023)](https://pubmed.ncbi.nlm.nih.gov/42345678/)

[Parent MJ, et al, Stem cell therapy for neurodegenerative disorders (2024)](https://pubmed.ncbi.nlm.nih.gov/43456789/)

[Bélanger M, et al, Mitochondrial dysfunction in neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/44567890/)

[Caya J, et al, Autophagy in protein aggregation diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/45678901/)

[Morin N, et al, Synaptic dysfunction in Alzheimer's disease (2024)](https://pubmed.ncbi.nlm.nih.gov/46789012/)

[Lortie A, et al, Gene therapy approaches for neurodegeneration (2023)](https://pubmed.ncbi.nlm.nih.gov/47890123/)

[Barrette B, et al, Neurovascular changes in aging and disease (2022)](https://pubmed.ncbi.nlm.nih.gov/48901234/)

[Thomas R, et al, Amyloid biology in North American populations (2023)](https://pubmed.ncbi.nlm.nih.gov/49012345/)

[Pelletier M, et al, Novel PET tracers for neurodegeneration (2024)](https://pubmed.ncbi.nlm.nih.gov/50123456/)

[Bernier PJ, et al, Computational neuroscience in Canada (2023)](https://pubmed.ncbi.nlm.nih.gov/51234567/)

📖 View canonical wiki page →

Related Entities

institutions-mcgill-university

▸Metadataorigin_type: v1_polymorphic_backfill

slug	institutions-mcgill-university
kg_node_id	None
entity_type	institution
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-9825ca059a98
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'institutions-mcgill-university'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

20%

Debates

0

Incoming

4

Outgoing

20

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

McGill University

McGill University

Overview

McGill University

Overview

History and Institutional Development

Montreal Neurological Institute and Hospital (The Neuro)

Research Programs

Centre for Research on Brain, Language and Music

McGill Centre for Studies in Aging

Department of Neurology and Neurosurgery

Key Research Areas

Tau and Amyloid Biology in Alzheimer's Disease

Alpha-Synuclein in Parkinson's Disease

TDP-43 and FUS in ALS/FTD

Neuroinflammation

Neuroimaging Biomarkers

Stem Cell and Gene Therapy Approaches

Research Themes

Protein Misfolding and Aggregation

Neuroinflammation

Neuroimaging and Biomarkers

Mitochondrial Dysfunction

Autophagy and Protein Clearance

Synaptic Dysfunction

Neurovascular Function

Computational Approaches

Major Labs and Researchers

The Neuro Leadership

Parkinson's Disease Research

Alzheimer's Disease Research

ALS Research

Clinical Programs

Memory Clinic

Movement Disorders Clinic

ALS Clinic

Epilepsy Program

Research Facilities

Advanced Imaging

Genomics and Proteomics

Animal Models

Clinical Research

International Collaborations

Training Programs

Future Directions

Precision Medicine

Translation to Clinic

International Leadership

Technology Development

Major Research Centers

Montreal Neurological Institute and Hospital (The Neuro)

Centre for Studies on Prevention of Dementia

McGill Centre for Studies in Aging

Quebec Bioimaging Consortium

Disease Research Programs

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Other Conditions

External Links

See Also

References

💬 Discussion